Skip to main content
Livermore
Livermore
ZHEN

Janney Montgomery Scott LLC

SEC CIK
0001329948
Latest filing
Aug 5, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Janney Montgomery Scott LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q2 2026)
13,087
Value
$3.20M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of AXSM by Janney Montgomery Scott LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,087$3.20M<0.1%+1,057+8.8%AddedHolders
Q1 202612,030$2.03M<0.1%+550+4.8%AddedHolders
Q4 202511,480$2.10M<0.1%−1,525−11.7%ReducedHolders
Q3 202513,005$1.58M<0.1%−18−0.1%ReducedHolders
Q2 202513,023$1.36M<0.1%−1,900−12.7%ReducedHolders
Q1 202514,923$1.74M<0.1%+1,178+8.6%AddedHolders
Q4 202413,745$1.16M<0.1%+6,546+90.9%AddedHolders
Q3 20247,199$647.0K<0.1%+1,569+27.9%AddedHolders
Q2 20245,630$453.0K<0.1%−150−2.6%ReducedHolders
Q1 20245,780$461.0K<0.1%+500+9.5%AddedHolders
Q4 20235,280$420.0K<0.1%−280−5.0%ReducedHolders
Q3 20235,560$389.0K<0.1%+1,073+23.9%AddedHolders
Q2 20234,487$322.0K<0.1%+4,487NewHolders
Q1 20230$00.0%−2,805−100.0%Sold outHolders
Q4 20222,805$216.0K<0.1%+2,805NewHolders
Q2 20220$00.0%−5,722−100.0%Sold outHolders
Q1 20225,722$237.0K<0.1%−327−5.4%ReducedHolders
Q4 20216,049$229.0K<0.1%+6,049NewHolders
Q3 20210$00.0%−10,540−100.0%Sold outHolders
Q2 202110,540$711.0K<0.1%+500+5.0%AddedHolders
Q1 202110,040$568.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.